Safety of Combining Azelastine with Brompheniramine

Introduction to Safety Concerns

The American College of Allergy, Asthma, and Immunology recommends avoiding the combination of azelastine with brompheniramine due to the risk of additive sedation and anticholinergic effects, which provides no additional therapeutic benefit while increasing adverse effects 1.

Azelastine alone demonstrates rapid onset within 15 minutes and sustained efficacy for 12-24 hours, eliminating the need for additional antihistamine therapy 1.

Azelastine nasal spray carries somnolence rates of 0.4% to 11.5%, though more recent studies show rates comparable to placebo at 0.4% to 3% 1.
Brompheniramine is a first-generation antihistamine with significant sedative properties and anticholinergic effects that impair cognitive function and driving ability 2, 3.
Combining these agents creates additive central nervous system depression, substantially increasing the risk of drowsiness, impaired performance, and accidents 2, 3.

Brompheniramine as a first-generation antihistamine produces anticholinergic effects including dry mouth, urinary retention, constipation, and cognitive impairment 2, 3.
This anticholinergic burden is particularly dangerous in elderly patients who are more sensitive to these effects 3.

Add intranasal fluticasone propionate to azelastine rather than another antihistamine, as this combination provides 40% greater relative improvement than either agent alone 4, 1.
The fluticasone-azelastine combination reduced Total Nasal Symptom Scores by 5.31-5.7 points compared to 3.25-4.54 for azelastine alone 4, 1.
Switch from brompheniramine to a second-generation oral antihistamine like fexofenadine 180 mg daily, which maintains non-sedating properties even at higher doses 2, 3.

If azelastine nasal spray alone is insufficient: Add intranasal fluticasone propionate, not an oral antihistamine 4, 1.
If systemic antihistamine is preferred: Discontinue brompheniramine and switch to fexofenadine 180 mg daily as monotherapy 2, 3.
If both nasal and systemic coverage are deemed necessary: Use azelastine nasal spray with fexofenadine oral, but recognize this provides minimal benefit over intranasal corticosteroid-antihistamine combination 4, 2.